These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 12459100)

  • 21. Safety in treating bipolar disorder.
    Gupta S
    J Fam Pract; 2003 Mar; Suppl():S26-9. PubMed ID: 12676082
    [No Abstract]   [Full Text] [Related]  

  • 22. Fatality from olanzapine induced hyperglycemia.
    Meatherall R; Younes J
    J Forensic Sci; 2002 Jul; 47(4):893-6. PubMed ID: 12137003
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute dystonia caused by low dosage of olanzapine.
    Alevizos B; Papageorgiou C; Christodoulou GN
    J Neuropsychiatry Clin Neurosci; 2003; 15(2):241. PubMed ID: 12724469
    [No Abstract]   [Full Text] [Related]  

  • 24. Olanzapine-induced somnambulism.
    Kolivakis TT; Margolese HC; Beauclair L; Chouinard G
    Am J Psychiatry; 2001 Jul; 158(7):1158. PubMed ID: 11431244
    [No Abstract]   [Full Text] [Related]  

  • 25. Exacerbation of chronic large plaque psoriasis associated with Olanzepine therapy.
    Ascari-Raccagni A; Baldari U; Rossi E; Alessandrini F
    J Eur Acad Dermatol Venereol; 2000 Jul; 14(4):315-6. PubMed ID: 11204528
    [No Abstract]   [Full Text] [Related]  

  • 26. Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics.
    Lindenmayer JP; Czobor P; Volavka J; Citrome L; Sheitman B; McEvoy JP; Cooper TB; Chakos M; Lieberman JA
    Am J Psychiatry; 2003 Feb; 160(2):290-6. PubMed ID: 12562575
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Olanzapine and haloperidol: potential for neutropenia?
    Abdullah N; Voronovitch L; Taylor S; Lippmann S
    Psychosomatics; 2003; 44(1):83-4. PubMed ID: 12515844
    [No Abstract]   [Full Text] [Related]  

  • 28. Olanzapine usage associated with neuroleptic malignant syndrome.
    Philibert RA; Adam LA; Frank FM; Carney-Doebbeling C
    Psychosomatics; 2001; 42(6):528-9. PubMed ID: 11815691
    [No Abstract]   [Full Text] [Related]  

  • 29. Olanzepine-induced tardive dyskinesia.
    Bella VL; Piccoli F
    Br J Psychiatry; 2003 Jan; 182():81-2. PubMed ID: 12509329
    [No Abstract]   [Full Text] [Related]  

  • 30. Neuroleptic malignant syndrome associated with olanzapine therapy.
    Apple JE; Van Hauer G
    Psychosomatics; 1999; 40(3):267-8. PubMed ID: 10341541
    [No Abstract]   [Full Text] [Related]  

  • 31. Olanzapine-induced hyperventilation: case report.
    Sattar SP; Gastfriend DR
    J Psychiatry Neurosci; 2002 Sep; 27(5):360-3. PubMed ID: 12271791
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Olanzapine-associated priapism.
    Gordon M; de Groot CM
    J Clin Psychopharmacol; 1999 Apr; 19(2):192. PubMed ID: 10211928
    [No Abstract]   [Full Text] [Related]  

  • 33. Olanzapine can worsen parkinsonism.
    Jiménez-Jiménez FJ; Tallón-Barranco A; Ortí-Pareja M; Zurdo M; Porta J; Molina JA
    Neurology; 1998 Apr; 50(4):1183-4. PubMed ID: 9566425
    [No Abstract]   [Full Text] [Related]  

  • 34. Pulmonary embolism possibly associated with olanzapine treatment.
    Waage IM; Gedde-Dahl A
    BMJ; 2003 Dec; 327(7428):1384. PubMed ID: 14670884
    [No Abstract]   [Full Text] [Related]  

  • 35. [Neuroleptic malignant syndrome and atypical antipsychotics].
    Canora Lebrato J; Bermúdez García JM; Alvarez García ML; Rico Irles J
    Med Clin (Barc); 2000 Sep; 115(7):279. PubMed ID: 11013157
    [No Abstract]   [Full Text] [Related]  

  • 36. Mania associated with olanzapine.
    London JA
    J Am Acad Child Adolesc Psychiatry; 1998 Feb; 37(2):135-6. PubMed ID: 9473906
    [No Abstract]   [Full Text] [Related]  

  • 37. Efficacy should drive atypical antipsychotic treatment.
    Citrome LL
    BMJ; 2003 Feb; 326(7383):283. PubMed ID: 12561827
    [No Abstract]   [Full Text] [Related]  

  • 38. Olanzapine and hypertriglyceridemia.
    Nguyen M; Murphy T
    J Am Acad Child Adolesc Psychiatry; 2001 Feb; 40(2):133. PubMed ID: 11211361
    [No Abstract]   [Full Text] [Related]  

  • 39. Olanzapine: weight gain and therapeutic efficacy.
    Gupta S; Droney T; Al-Samarrai S; Keller P; Frank B
    J Clin Psychopharmacol; 1999 Jun; 19(3):273-5. PubMed ID: 10350036
    [No Abstract]   [Full Text] [Related]  

  • 40. Olanzapine-induced agranulocytosis.
    Naumann R; Felber W; Heilemann H; Reuster T
    Lancet; 1999 Aug; 354(9178):566-7. PubMed ID: 10470705
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.